Results 231 to 240 of about 1,122,121 (342)

Genetic correlation and causal relationship between sleep and myopia: a mendelian randomization study. [PDF]

Front Genet
Zhu G, Tian R, Zhou D, Qin X.
europepmc   +1 more source

Ovulation rate and twinning rate in cattle: heritabilities and genetic correlation.

, 1991
L.D. Van Vleck, K. E. Gregory, S. E. Echternkamp   +2 more
openalex   +2 more sources

Negative genetic correlation between traits of the Drosophila head, and interspecific divergence in head shape [PDF]

, 2000
Fabian M. Norry, Juan C. Vilardi, Esteban Hasson   +2 more
openalex   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

Genetic correlation between genes targeted by lipid-lowering drugs and venous thromboembolism: A drug-target Mendelian randomization study. [PDF]

Medicine (Baltimore)
Li M, Duan H, Luo J, Tan Y, Liu M, Zhao X, Shi D, Ma X.   +7 more
europepmc   +1 more source

Correlations for genetic expression for growth of calves of Hereford and Angus dams using a multivariate animal model2

, 1993
Rafael Núñez-Domínguez, L.D. Van Vleck, K. G. Boldman, L. V. Cundiff   +3 more
openalex   +2 more sources

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

Molecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu, Ning Ding, Xiaobo Xu, Yedan Chen, Yong Zhang, Jingwen Liu, Jiebai Zhou, Hairong Bao, Donghui Zhang, Yijun Song, Yang Shao, Yuanlin Song   +11 more
wiley   +1 more source

Casual associations between brain structure and sarcopenia: A large-scale genetic correlation and mendelian randomization study. [PDF]

Aging Cell
Yang G, Xie W, Li B, Zhao G, Li J, Xiao W, Li Y.   +6 more
europepmc   +1 more source

Correlation of physical and genetic maps of human chromosome 16

, 1990
G.R. Sutherland
openalex   +1 more source

MIF as an oncogenic driver of low‐heterogeneity melanomas

Molecular Oncology, EarlyView.
Shvefel and colleagues identified tumor‐secreted macrophage migration inhibitory factor (MIF) as an upregulated cytokine that mediates immune resistance in melanomas with low‐intratumoral heterogeneity. MIF and its functional paralogue D‐dopachrome tautomerase (D‐DT or MIF‐2) have overlapping but nonidentical signaling functions and are hypothesized to
Thuy T. Tran, Gabriela Athziri Sánchez‐Zuno, Rajan P. Kulkarni, Harriet M. Kluger, Richard Bucala   +4 more
wiley   +1 more source